Hengrui Pharma, a Chinese biopharma company with clinical development programs across oncology, anesthesiology & pain management, autoimmune, and metabolic & cardiovascular diseases, has recently adopted Medidata Cloud, the Intelligent Platform for Life Sciences, to accelerate global drug research. Hengrui selected the Medidata cloud platform in the third quarter of this year to unify data management and…
